1
/
of
10
www.ChineseStandard.us -- Field Test Asia Pte. Ltd.
YY/T 0771.2-2020 English PDF (YY/T0771.2-2020)
YY/T 0771.2-2020 English PDF (YY/T0771.2-2020)
Regular price
$695.00
Regular price
Sale price
$695.00
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
YY/T 0771.2-2020: Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and handling
Delivery: 9 seconds. Download (and Email) true-PDF + Invoice.Get Quotation: Click YY/T 0771.2-2020 (Self-service in 1-minute)
Newer / historical versions: YY/T 0771.2-2020
Preview True-PDF
Scope
This Part of YY/T 0771 specifies the control requirements for the sourcing, collectionand handling (including storage and transportation) of animals and tissues used to
manufacture medical devices made from animal-derived materials, excluding in vitro
diagnostic medical devices. The risk management process requirements given in YY/T
0771.1-2020 apply.
Note 1: The selection of animal sources is particularly important for the risk
management of transmissible spongiform encephalopathy (TSE).
This Part of YY/T 0771 does not cover medical devices using human tissues.
This Part of YY/T 0771 does not specify a quality management system for controlling
the whole process of medical device production.
YY/T 0771 does not cover the overall quality management system for production, but
specifies requirements for certain elements of the quality management system.
Attention is drawn to the standards for quality management systems for controlling the
whole process of production or reprocessing of medical devices (see YY/T 0287). The
quality management system elements required by this Part may form part of a quality
management system conforming to YY/T 0287.
Note 2: The basic principle for the application of YY/T 0771 is to give appropriate
consideration to the requirements and recommendations in all three Parts of
the standard.
Basic Data
| Standard ID | YY/T 0771.2-2020 (YY/T0771.2-2020) |
| Description (Translated English) | Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and handling |
| Sector / Industry | Medical Device and Pharmaceutical Industry Standard (Recommended) |
| Classification of Chinese Standard | C30 |
| Classification of International Standard | 11.100.20 |
| Word Count Estimation | 17,156 |
| Date of Issue | 2020 |
| Date of Implementation | 2021-04-01 |
| Issuing agency(ies) | State Drug Administration |
| Summary | This standard specifies the control requirements for the source, collection and disposal (including storage and transportation) of animals and tissues for medical devices manufactured from materials of animal origin, excluding in vitro diagnostic medical devices. The risk management process requirements given in YY/T 0771.1-2020 apply. This standard does not cover medical devices using human tissue. This standard does not specify a quality management system that controls the entire process of medical device production. YY/T 0771 does not deal with the overall quality management system in production, but specifies the requirements for certain elements of the quality management system, paying attention to the quality management system standards for controlling the entire process of medical device production or reprocessing (see YY/T 0287). The elements of the quality management system required by this standard can form a quality management system that conforms to YY/T 0287 |
Share
